The first sa-mRNA vaccine to reach any market was Gennova Biopharmaceuticals' Gemcovac, which was launched in India in 2022 ...

MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Global biotechnology leader CSL (ASX: CSL; USOTC: CSLLY) and sa-mRNA pioneer Arcturus Therapeutics (Nasdaq: ARCT) today ...

A bill that would ban the use of mRNA vaccines, including for Covid-19, is on its way to the House floor after passing out of committee in a party-line vote Wednesday. Sponsored by Rep. Greg Kmetz, ...

你是否曾想过，新冠病毒（Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2）可能在感染后多年内悄悄地影响我们的大脑？来自德国慕尼黑亥姆霍兹中心和慕尼黑大学的研究人员最近发现了一种机制 ...

Biotech firm Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to ...

Moderna (NASDAQ:MRNA) stock drops ~5% as its Q4 2024 results show revenue beat but earnings miss expectations. Read more here ...

Biotechnology company Moderna (NASDAQ:MRNA) in Q4 CY2024, but sales fell by 65.6% year on year to $966 million. On the other ...

They do not contain weakened or inactivated viruses. Instead, they do contain a type of genetic information (called mRNA) with instructions on how to create copies of the coronavirus’s ‘spike’ protein ...

The latest move is another step in the Trump administration’s campaign against Covid-19 vaccine requirements. Read more at ...

COVID-19 vaccination is linked to a transient decrease in hyperthyroidism risk but an increase in hypothyroidism risk over 12 ...